Epidemiology and Prevention of Cardiovascular Diseases: A Global ChallengeJones & Bartlett Learning, 1998 - 681 pages This comprehensive textbook presents major epidemiological research and practical prevention strategies for cardiovascular disease. Your students will develop a firm foundation of knowledge on this major issue of worldwide concern. Learn the major causes and determinants. Discover the latest strategies for prevention and disease management. And understand the effects of cardiovascular disease on industrialized and developing countries. Features include state-of-the-art research examples from the worldwide literature....more than 300 tables, figures, and exhibits... 14 chapters devoted to causes of cardiovascular disease...insights for clinical and preventive practice...and much more. With a unique global perspective, this text is the superlative choice for courses in cardiovascular epidemiology or the epidemiology of chronic disease. |
From inside the book
Results 6-10 of 83
Page 47
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 54
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 57
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 58
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 62
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Contents
35 | 8 |
Conclusion | 15 |
Early Development of Atherosclerosis and Its Relation to the Major | 33 |
Treatment and Prevention of Atherosclerosis | 39 |
Algorithms and Criteria | 48 |
Risks in Individuals | 63 |
Chapter 5Stroke | 73 |
Chapter 6Other Major Conditions | 91 |
Chapter 15Alcohol Consumption | 347 |
Chapter 16Hemostatic Dysfunction | 369 |
Chapter 17Adverse Psychosocial Patterns | 393 |
Chapter 18Other Personal Characteristics | 411 |
Chapter 19Social Conditions | 423 |
Chapter 20The Causal Complex | 449 |
Some Implications of Experience with Multifactor Intervention | 492 |
Chapter 22The Evolution of Prevention Policies | 499 |
Aortic Aneurysm | 100 |
Deep Vein Thrombosis and Pulmonary Embolism | 113 |
Chapter 7Age Sex Race and Heredity | 119 |
Chapter 8Dietary Imbalance | 133 |
Chapter 9Physical Inactivity | 167 |
Chapter 10Fatness Overweight and Central Adiposity | 193 |
Chapter 11Adverse Blood Lipid Profile | 223 |
Chapter 12High Blood Pressure | 261 |
Chapter 13Glucose Intolerance Insulin Resistance and Diabetes | 293 |
Chapter 14Smoking and Other Tobacco Use | 323 |
Chapter 23Groups of Special Concern | 523 |
PART IVOTHER MAJOR CARDIOVASCULAR DISEASES | 537 |
Chapter 25Chagas Disease and Other Cardiomyopathies | 567 |
Chapter 26Congenital Heart Disease | 585 |
Chapter 27Kawasaki Disease | 611 |
PART VACHIEVING THE POTENTIAL FOR CARDIOVASCULAR | 623 |
Chapter 29Advancement of Epidemiologic Research for the Prevention | 649 |
663 | |
Other editions - View all
Epidemiology and Prevention of Cardiovascular Diseases: A Global Challenge Labarthe Limited preview - 2010 |
Common terms and phrases
acute adults alcohol American Heart Association aneurysm atherosclerosis baseline behavior blood lipid body mass index cardiac cardiomyopathy cardiovascular diseases causation Chagas Chapter cholesterol concentration chronic cigarette clinical cohort congenital heart disease coronary events coronary heart disease countries defects diabetes diastolic diet dietary differences effects epidemiology evaluation fibrinogen Figure follow-up genetic glucose groups heart failure high blood pressure high-risk incidence included increased indicated individual infection insulin intake intervention ischemic heart disease Kawasaki disease levels lipid lipoprotein measures mg/dl mortality myocardial infarction obesity occur patterns physical activity population population-wide potential prevalence prevention programs public health reduce relation relative risk Reprinted with permission rheumatic fever rheumatic heart disease risk factors serum smoking social Source specific strategies stroke studies surveys Table tion tobacco total cholesterol treatment trends trials United vascular vention women World Health Organization